Drugs / Meningococcal Polysaccharide Diphtheria Conjugate Vaccine
Meningococcal Polysaccharide Diphtheria Conjugate Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00422292 | Dec 2006 → Jan 2009 | chickenpox, measles, meningococcal meningitis, mumps infectious disease +1 | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Meningococcal Polysaccharide Diphtheria Conjugate Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00422292 ↗ |
| Modality | Vaccine | “Menactra vaccine” NCT00422292 ↗ |
| Route | Intramuscular | “0.5 mL dose, intramuscular (IM)” NCT00422292 ↗ |